Henri Hofland
Cancer is increasingly recognized not merely as a genetic disease but as a disorder of metabolism. At its core, cancer cells exhibit profound alterations in energy utilization, relying heavily on glucose and glycolysis even in the presence of oxygen-a phenomenon known as the Warburg effect. This metabolic rigidity renders tumor cells vulnerable to strategies that limit glucose availability, enhance mitochondrial function in healthy cells, and support systemic resilience. The ketogenic diet, a high-fat, moderate-protein, low-carbohydrate nutritional approach, emerges as a powerful tool to exploit these vulnerabilities while promoting overall cellular health.Ketogenic nutrition shifts the body’s energy reliance from glucose to ketones, a stable alternative fuel produced by the liver from fatty acids. Healthy cells adapt efficiently to ketone metabolism, enhancing mitochondrial efficiency, reducing oxidative stress, and maintaining energy production under conditions of limited carbohydrate intake. Cancer cells, in contrast, often struggle to utilize ketones due to impaired mitochondrial function, making them more susceptible to metabolic stress. By creating this differential metabolic environment, ketogenic nutrition can selectively support healthy tissues while placing tumor cells at a relative disadvantage, complementing conventional therapies and providing a foundation for integrative cancer care.Beyond its metabolic effects, the ketogenic diet exerts anti-inflammatory and immunomodulatory actions. Chronic inflammation is a key driver of tumor progression, and the reduction of glucose and insulin levels through ketosis downregulates pro-inflammatory pathways while supporting immune cell function. Immune cells, particularly T cells and natural killer cells, rely on flexible energy sources, and ketone metabolism can sustain their activity even under conditions of metabolic stress. Emerging evidence suggests that ketogenic nutrition may synergize with immunotherapies, chemotherapy, and radiation by optimizing the metabolic landscape in which both healthy and malignant cells operate.Implementing a therapeutic ketogenic plan requires careful attention to macronutrient composition, hydration, electrolytes, and individualized adjustments based on biomarkers, cancer type, and treatment status.
